Impact of early vs. delayed intravenous magnesium sulfate on clinical outcomes in pediatric severe asthma: a retrospective cohort study

BackgroundIntravenous magnesium sulfate (IV MgSO4) is a recommended second-line therapy for children with severe asthma exacerbations unresponsive to initial treatment. While its efficacy in reducing bronchospasm is supported by several studies, the optimal timing of administration in the emergency...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Mohammid Alzain, Sajjad Alkhadem, Rafa Alotbi, Ibrahim Alammari, Norah Aljabri, Reem Almijlad, Shahd Abureesh, Hadeel Alharbi, Rawan Alrashed, Yara Algoraini
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2025-11-01
Schriftenreihe:	Frontiers in Disaster and Emergency Medicine
Schlagworte:	pediatric asthma intravenous magnesium sulfate emergency care PRAM score early intervention asthma exacerbation
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/femer.2025.1689282/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!